Clinical Trial Update: Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial from University Hospital, Strasbourg, France, is recruiting rheumatoid arthritis patients with inadequate response to methotrexate or l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Leflunomide (Leflunomide)
• METHOTREXATE (METHOTREXATE)
• Sulfasalazine (Sulfasalazine)
• Targeted therapy

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Rheumatoid Arthritis, Insufficient Response to Methotrexate or Leflunomide | Phase 4 | Status: RECRUITING